Overview 

The TEG® system provides a global test of hemostasis that can identify whether the patient is bleeding due to surgical, coagulopathy, or residual heparin. If the patient has a coagulopathy, the TEG® system will identify the specific therapy to treat it, whether he needs FFP, cryo, platelets, or antifibrinolytic drugs. In fact, these therapies can first be applied in vitro to confirm their effect on the patient sample before the patient himself is treated.